Your browser doesn't support javascript.
loading
Cognitive intraindividual variability as a potential biomarker for early detection of cognitive and functional decline.
Scott, Bonnie M; Austin, Tara; Royall, Donald R; Hilsabeck, Robin C.
Afiliação
  • Scott BM; Department of Neurology, Dell Medical School, University of Texas at Austin.
  • Austin T; Doris Miller Department of Veterans Affairs Medical Center, Veterans Affairs Center of Excellence for Research on Returning, War Veterans.
  • Royall DR; Department of Psychiatry, University of Texas Health Science Center at San Antonio.
  • Hilsabeck RC; Department of Neurology, Dell Medical School, University of Texas at Austin.
Neuropsychology ; 37(1): 52-63, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36227289
OBJECTIVE: Intraindividual variability (IIV) in cognitive performance has been associated with cognitive decline and reductions in white matter integrity, but the predictive utility of IIV-between versus IIV-within domains is unknown. The present study aimed to determine if IIV-within a "frontal-subcortical" domain may be a more robust predictor of changes in general cognitive status and functional independence over time than IIV-between cognitive domains. METHOD: Mixed linear modeling was used to analyze the relationship between cognitive IIV and cognitive and functional status in 651 controls, 211 people with mild cognitive impairment, and 218 people with Alzheimer's disease over a 5-year period. RESULTS: Both IIV-between and IIV-within a frontal-subcortical domain improved prediction of cognitive and functional declines beyond demographic characteristics, genetic risk, and vascular integrity. IIV-between showed the greatest effect over time and was driven primarily by increases in IIV-within. CONCLUSIONS: Cognitive IIV, especially between cognitive domains, may be useful for identifying individuals at risk for cognitive and functional decline. Findings may facilitate investigations into mechanisms underlying declines in global cerebral integrity and aid clinical trials aimed at early detection and treatment. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Neuropsychology Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Neuropsychology Ano de publicação: 2023 Tipo de documento: Article